Genesis Global Group

You will now be redirected to the GD3 website

Invivotek is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.

Learn more about GD3


We perform discovery in vivo pharmacokinetic studies in isolation and in combination with pharmacodynamics/ efficacy/ toxicity evaluations. The correlation of PK and functional read-outs helps elucidate the relationship between PK and PD, understand the mechanism of drug action, and identify PK properties for further improvement and optimal compound design.

Discovery in Vivo Pharmacokinetic Services:

  • Collection of Blood and Tissues from Test-Agent-Treated Mice and Rats for Bioanalysis
  • In vivo PK Screens
    • Clearance/ Half-Life/ Bioavailability
    • Target Organ Penetration
  • Pharmacology Support
    • Exposure in Efficacy Models
  • Toxicology Support
    • Exposure in Discovery Toxicology Studies
  • Bioanalytical Services